investigating conformation specific drug targets of human thymidilate synthase ukegbu b. iroha...

13
Investigating conformation specific drug targets of human Thymidilate synthase Ukegbu B. Iroha Department of Pharmaceutical sciences, University of South Carolina, Columbia. Mentor: Dr. Sondra Berger December 10, 2004.

Post on 20-Dec-2015

213 views

Category:

Documents


0 download

TRANSCRIPT

Investigating conformation specific drug targets of human Thymidilate

synthase

Ukegbu B. IrohaDepartment of Pharmaceutical sciences, University of South Carolina, Columbia.

Mentor: Dr. Sondra Berger

December 10, 2004.

Introduction/Objective

• Cancer

• Thymidilate Synthase

• Background

• Aim of research

TS

N

NH

O

O

R

N

NH

O

O

R

CH3

dUMP dTMP

N

NN

N

NNHOH

O

NH2

O

H

OH

O

O

H

N

NN

N

NHNHOH

O

NH2

O

H

OH

O

O

H

mTHFDHF

Thymidylate Synthase (TS)Reaction Pathway

Role of Thymidylate Synthase

Thymidylate Synthase Structure

• Nucleophilic Cys is located in the active site cleft

Cys180°

Cys

Native Complexed

MethodConstructing Mutant TS proteins

PCRrxn

Dpn Idigest

TX61-

Growth Conditions+/- exogenous

Thymidine

Protein purificationFPLC

blue sepharosesepharose Q

catalyticactivity

LigandBindinganalysis

3-D structure determination

JM109

Creating V3A mutant

• dH2O -37.5l

• 10x Pfu Buffer -5.0l

• DtNps -1.0l

• Templates -1.0l

• Primer1(SB229) -2.5l

• Primer 2(SB230)-2.5l

• Pfu Turbo -0.5l

50l

Mutation primer sequence position

V3A SB229 5`-TTA TGC CTG CTG CTG GTT C-3`

SB230 5`-GAA CAA GCA GCA GGC ATA A-3`

DPNI digest

PCR

Transformation on [Tx61-] cells

Plasmid purification

• Grew 10ml overnight culture• Use Qiagen plasmid mini-prep purification kit

protocol

Western blot analysis of Active and inactive stabilized mutants of hts in TX61- cells.

• 10ml overnight culture were sonicated in Buffer A• Remove cellular debris by centrifugation• Use bradford assay to determine concentration of total

soluble protein• Load protein in well.

bradford assay

0

0.05

0.1

0.15

0.2

0.25

0.3

0.35

0.4

0 2 4 6 8 10 12 14

concentration g/l

abso

rbsa

nce

59

5

Mutant protein SLB load

HtsTx61-V3A

232632

8 9 11

15 17 21

y = 0.0483x + 0.0007R2 = 0.9898

Future Direction

• Characterization of V3A

Activity assay

Ligand binding (DUMP ligands)

Reactivity of Catalytic cystine• Structural Determination

Crystallization of protein.

Acknowledgement

• Dr. Sondra Berger• Saphronia Johnson• Brittnaei Bell• Dr. Omar Bagasra• Twaina Harris• Claflin University• University of South Carolina, Columbia• National Cancer Institute